Nektar Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRDF | D | Cardiff Oncology, Inc. | 4.45 | |
NKTR | D | Nektar Therapeutics | 2.31 |
Related Industries: Biotechnology Diagnostics & Research
Related Stock Lists:
Colorectal Cancer
Drugs
Metastatic Colorectal Cancer
Pharmaceutical
Acute Myeloid Leukemia
Acute Pain
Adenosine
Advanced Solid Tumors
Aminoglycoside
Anti Infectives
Antibiotics
Antineoplastic Drugs
Biopharmaceutical
Biotechnology
Breast Cancer
Cancer
Cancer Treatment
Chemotherapy
Chronic Pain
Clinical Development
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 0.48 | |
IWC | C | iShares Microcap ETF | 0.09 | |
PRFZ | C | PowerShares FTSE RAFI US 1500 Small-Mid Portfolio | 0.03 | |
GSSC | C | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02 | |
IWN | C | iShares Russell 2000 Value ETF | 0.02 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Sep 30 | NKTR | Nektar rises 11% as BTIG initiates buy rating on autoimmune disorders asset |
Related Industries:
Biotechnology
Diagnostics & Research
Related Stock Lists:
Colorectal Cancer
Drugs
Metastatic Colorectal Cancer
Pharmaceutical
Acute Myeloid Leukemia
Acute Pain
Adenosine
Advanced Solid Tumors
Aminoglycoside
Anti Infectives
Antibiotics
Antineoplastic Drugs
Biopharmaceutical
Biotechnology
Breast Cancer
Cancer
Cancer Treatment
Chemotherapy
Chronic Pain
Clinical Development
- Nektar Therapeutics
Nektar Therapeutics (Nektar) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles